Key structural and functional differences between early and advanced glycation products.

Area of Science:

• Biochemistry
• Cell Biology
• Vascular Biology

Background:

• Advanced glycation end products (AGEs) are implicated in diabetic complications but often studied as uncharacterized mixtures.
• Structural characterization of specific AGEs is crucial for understanding their distinct biological effects.
• Endothelial dysfunction is a key feature of diabetic vascular disease, involving oxidative stress and altered cell adhesion.

Purpose of the Study:

• To structurally characterize and compare the effects of low (glycated human serum albumin, gHSA) and high (AGE-human serum albumin, AGE-HSA) levels of protein glycation on endothelial cells.
• To investigate the distinct impacts of gHSA and AGE-HSA on reactive oxygen species (ROS) production, adhesion molecule expression, and mononuclear cell adhesion.
• To elucidate the functional differences between early and advanced glycation products in the context of endothelial functionality.

Main Methods:

• MALDI-TOF mass spectrometry was used to characterize glycation and composition of gHSA and AGE-HSA.
• Human umbilical endothelial cells (HUVEC) were treated with gHSA and AGE-HSA to assess reactive oxygen species (ROS) production.
• Expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular cell adhesion molecule-1 (ICAM-1) at mRNA and protein levels was measured.
• Adhesion of peripheral blood mononuclear cells (PBMC) to HUVEC monolayers was quantified.

Main Results:

• Low concentrations of gHSA induced sustained ROS production in HUVEC, while AGE-HSA accelerated ROS production.
• Both gHSA and AGE-HSA upregulated VCAM-1 and ICAM-1 mRNA expression in HUVEC.
• Only AGE-HSA significantly increased VCAM-1 and ICAM-1 protein levels and enhanced PBMC adhesion to HUVEC.
• AGE-HSA demonstrated a more pronounced pro-oxidant effect and functional increase in cell adhesion compared to gHSA.

Conclusions:

• Distinct structural differences between gHSA and AGE-HSA lead to differential effects on endothelial cell function.
• Advanced glycation (AGE-HSA) plays a more critical role in promoting oxidative stress and endothelial cell adhesion than early glycation (gHSA).
• These findings highlight the specific contribution of AGEs to diabetic vascular complications and suggest potential therapeutic targets.